RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 25.0%, EPS fell 47.4%, free cash flow fell 43.2% and total debt rose 21.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

68.53 1.88 −2.67%
Market cap
$5.5B
P/E
0.0×
Fwd P/E
279×
Dividend yield
—
F-score
3/9
Altman Z
2.04
Beneish M
−2.62
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
2.11 2.01 2.63 2.94
P/FCF ratio
148.47 70.09 119.74 573.94
P/Operating CF
50.98 54.54 63.74 109.57
P/B ratio
3.44 3.18 3.96 4.41
EV/Sales
2.38 2.30 2.79 3.09
EV/EBITDA
17.55 17.05 20.37 22.35
EV/FCF
167.21 80.41 126.94 602.78
Current Ratio
1.48 1.17 1.76 1.87
Net Debt/EBITDA
5.68 15.96 3.81 3.22
Debt/Equity
0.94 0.79 0.80 0.82
Earnings Yield
(0.44%) (0.32%) (0.35%) (0.22%)
Free Cash Flow Yield
0.67% 1.43% 0.84% 0.17%
Free Cash Flow per Share
0.49 0.12 0.46 (0.10)
Book value per Share
17.92 17.55 18.03 17.30
Free Cash Flow
38.28 9.32 34.35 (7.58)
EV/EBIT
76.33 79.45 91.75 103.57
Other line items

Show all line items

Columns are period end dates